The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients
Ting‐Hui Liu, Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, Chih‐Cheng Lai
Topics & Concepts
RitonavirEpilepsyCoronavirus disease 2019 (COVID-19)Retrospective cohort studyMedicineCohortTerm (time)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort studyPediatricsInternal medicineVirologyHuman immunodeficiency virus (HIV)PsychiatryAntiretroviral therapyViral loadDiseasePhysicsOutbreakQuantum mechanicsInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 and Mental HealthMultiple Sclerosis Research Studies